医学
冲程(发动机)
蛛网膜下腔出血
急性中风
2019年冠状病毒病(COVID-19)
脑出血
大流行
急诊医学
内科学
儿科
组织纤溶酶原激活剂
疾病
机械工程
工程类
传染病(医学专业)
作者
Hiroshi Yamagami,Nobuyuki Ohara,HIROTOSHI IMAMURA,Nobuyuki Sakai,Teruyuki Hirano,Yoichiro Hashimoto,Kuniaki Ogasawara,Susumu Miyamoto
出处
期刊:Stroke
[Ovid Technologies (Wolters Kluwer)]
日期:2022-02-01
卷期号:53 (Suppl_1)
被引量:1
标识
DOI:10.1161/str.53.suppl_1.tmp23
摘要
Background and Purpose: We sought to investigate the impact of COVID-19 pandemic on number of acute stroke patients admitted to Japanese primary stroke centers (PSCs). Methods: The Japan Stroke Society and the MHLW registry of mechanical thrombectomy for acute ischemic stroke conducted a national annual survey of hospitalization volumes for acute ischemic stroke, intracranial cerebral hemorrhage, and subarachnoid hemorrhage in PSCs. Number of acute stroke patients was defined as sum of three stroke subtypes admitted within 7 days after the onset. Monthly acute stroke volumes were compared between 2019 and 2020, among COVID-19 waves, and regional infectious rates. Results: The stroke volume data was completed in 530 PSCs. The annual acute stroke volume was declined 2.5% from 179,893 in 2019 to 174,385 in 2020. Number of acute stoke patients was declined during COVID-19 expanding periods (1 st wave, Mar-May; 2 nd wave Jul-Aug; 3 rd wave Nov-Dec), whereas it was increased in the other months. The mean decline rate of stroke volumes from 2019 to 2020 was greater in 125 PSCs located in prefectures with high estimated SARS-CoV 2 infected rate (more than 2,300 per million people) than in 405 PSCs of the other regions (-4.6±15.4% vs -0.1±20.0%, P=0.008), especially during COVID-19 expanding periods (-8.2±17.9% vs -3.1±21.3%, P=0.009). Conclusions: Acute stroke volumes were declined in 2020 from 2019 in Japanese PSCs, especially during COVID-19 expanding periods and in highly infected regions. The overwhelmed health care system and infection control practices may have associated with decline of number of acute stroke patients during COVID-19 pandemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI